Entry Point Capital, LLC Castle Biosciences Inc Call Options Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CSTL
# of Institutions
201Shares Held
24.5MCall Options Held
303KPut Options Held
30.3K-
Black Rock Inc. New York, NY3.04MShares$81.7 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.83MShares$49 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$46.9 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.26MShares$33.9 Million0.61% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.26MShares$33.7 Million2.85% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $706M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...